Origin Materials clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Origin Materials Inc
ORGN · NASDAQ · USD · Market cap $5M · 98 employees
Origin Materials, Inc., together with its subsidiaries, engages in the polyethylene terephthalate (PET) closures business in California.
Not yet scoredPrice as of 2 Sep 2026Daily close, not a live quoteLast reviewed 56 days ago
Screened 2026-09-02 · the tape above runs as of 18:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price0.95 USD at the 2 Sep 2026 close
- Ethical screenNot yet scored
- Last reviewed2 Sep 2026 (56 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 0.95 against the desk's fair-value range, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Origin Materials Inc holds its Markdown at $0.95. Elevated stress, defensive posture warranted, held for 1 days.
| Phase | Markdown · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 1 days |
| Price at the screen | $0.95 |
| Valuation | N/A trailing · -2.71 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.14 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 17.57% | Below 33% | Interest-bearing debt is just 17.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 13.03% | Below 33% | Cash held in interest-bearing accounts and securities is 13.0% of assets, under the one-third limit. | Pass |
| Receivables | 29.16% | Below 49% | Money owed to the company is 29.2% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Origin Materials clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Origin Materials clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
The Business, in Plain Words| Forward P/E | -2.7x |
| EPS, trailing | -48.43 |
| EPS, forward | -0.35 |
| Revenue growth | -91.2%revenue is shrinking |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | -119.6%not currently earning a positive return on equity |
| FCF yield | -718.50% |
| Debt to equity | 0.26minimal debt: a conservative balance sheet |
| Current ratio | 2.66comfortably covers its short-term bills |
| Beta | 1.14moves a little more than the market |
| Short interest, float | 0.06% |
| 52-week range | 0.82 - 28.50 |
| Moat | NONE |
| Market cap | $5M |
| Employees | 98 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeORGN trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 91%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 91%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 91%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 14.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 91%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 91%. Our forward projection puts the odds of a 10% gain over the next month near 17%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Origin Materials approves delisting to cut compliance costs Packaging Gateway · 12 Jun 2026
- Amcor, Hilex Poly, Origin Materials announced closures in May Packaging Dive · 3 Jun 2026
- Origin Materials, Inc. Q4 2025 Earnings Call Summary Moby · 28 Mar 2026
- Origin Materials and HP Embalagens enter PET cap distribution deal Packaging Gateway · 20 Mar 2026
- Origin Materials and Matrix Bottling partner to develop recyclable caps Packaging Gateway · 27 Feb 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1.30 | -5.4% | · | $946 | -5.4% |
| 2 months | $1.95 | -36.9% | · | $631 | -36.9% |
| 3 months | $3.75 | -67.2% | · | $328 | -67.2% |
| 6 months | $13.29 | -90.7% | · | $93 | -90.7% |
| 1 year | $14.25 | -91.4% | · | $86 | -91.4% |
| 2 years | $31.20 | -96.1% | · | $39 | -96.1% |
| 3 years | $141.00 | -99.1% | · | $9 | -99.1% |
| 5 years | $299.70 | -99.6% | · | $4 | -99.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ORGN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.